KWKathryn Alice Wood

Kathryn Alice Wood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kathryn Alice Wood has a total of 305 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Review of Experiential Learning Approaches for Teaching Prelicensure Research

    by Kathryn A. Wood, Priscilla W. Hartley, Signe Stelling-Risom

    Background: Often prelicensure students may not appreciate the importance of research and may question the need for a research course. Application of experiential learning strategies to blend immersion experiences with active learning provides students opportunities to develop critical thinking and decision making, strengthening the practice–research interconnection. Method: We searched nursing education literature to identify experiential learning strategies used in teaching nursing research to prelicensure students. Databases searched include PubMed (National Library of Medicine), CINAHL (EBSCO), Education Resources Information Center (EBSCO), and Education Source (EBSCO). Results: A total of 1,055 articles initially identified were narrowed down to 29 final reports. Experiential learning methods within a formal research course and in lieu of a formal course were found useful in teaching nursing research content. Conclusion: A variety of innovative experiential strategies exist to enhance learning and the practice–research interconnection. These foster a deeper understanding and greater appreciation for research as it relates to nursing practice and the preparation for diverse career pathways.

  • Effect of atrial fibrillation on progression of cognitive impairment in patients with and without prior stroke

    by Kathryn A. Wood, Yi-An Ko, T. Jared Bunch, Feier Han, Whitney Wharton

  • Open Access

    Predicting Atrial Fibrillation Ablation Outcomes: Machine Learning Model Development and Validation Using a Large Administrative Claims Database

    by Yijun Liu, Mustapha Oloko-Oba, Kathryn A Wood, Michael S Lloyd, Joyce C Ho, Vicki Stover Hertzberg

    Background: Atrial fibrillation (AF) ablation is an effective treatment for reducing episodes and improving quality of life in patients with AF. However, long-term AF-free rates after AF ablation are inconsistent across the population, ranging from 50% to 75%. Patient selection relies on individual clinical assessment, highlighting a critical gap in population-level predictive analytics. While existing risk scores (eg, CHADS ₂ [congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, and stroke], CHA ₂ DS ₂ -VASc [congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke, vascular disease, age, and sex category], CAAP-AF [coronary artery disease, left atrial diameter, age, AF, antiarrhythmic drugs, and female sex category]) have been applied to predict AF ablation outcomes, their performance in administrative claims data remains unclear. Leveraging large administrative claims databases represents an opportunity to develop standardized, scalable prediction models that could inform population health management and resource allocation at a national level. Objective: This study utilizes machine learning (ML) models on claims data to explore if integrating International Classification of Diseases ( ICD ) billing codes outperforms traditional stroke and AF risk scores in predicting 1-year AF ablation outcomes. Methods: We analyzed claims data from the Merative MarketScan Research Medicare database (2013‐2020) to identify 14,521 patients who underwent AF ablation. To predict 1-year AF-free outcomes, we developed logistic regression and extreme gradient boosting (XGBoost) models using demographic characteristics, comorbidity indices, and ICD diagnostic codes from the 2 years preceding ablation. Model predictions were compared with claims-based implementations of established risk scores—CHADS 2 , CHA 2 DS 2 -VASc, and a modified CAAP-AF (without left atrial diameter and the number of failed antiarrhythmic drugs). The ML models were also assessed on subgroups of patients with paroxysmal AF, persistent AF, and both AF and atrial flutter from October 2015 onward. Results: Among 14,521 patients (mean age 71.5, SD 5.31 y; n=5800, 39.94% female), AF ablation success occurred in 54.01% (n=7843). XGBoost achieved areas under the receiver operating characteristic curve (AUCs) of 0.528, 0.521, and 0.529 for the whole, female, and male AF ablation groups, respectively, and better discrimination than CHADS 2 , CHA 2 DS 2 -VASc, and the modified CAAP-AF in all AF ablation groups (whole population, female, and male). While CHA 2 DS 2 -VASc and the modified CAAP-AF showed higher recall (>0.798), their precision (International Classification of Disease, Tenth Revision ( ICD-10 ) patients (n=7646), the models incorporating ICD codes demonstrated better performance than those using only demographic and comorbidity data across most AF subtypes, with the highest AUC (0.544) observed in patients with paroxysmal AF. Conclusions: While the ML models achieved statistically significant improvements over claim-based implementations of established clinical risk scores (AUC 0.528‐0.544 vs 0.498‐0.505), the modest predictive performance highlights challenges in predicting procedural outcomes using administrative data that lack key clinical variables (eg, left atrial size and medication details). Our findings establish that while standardized outcome prediction using nationally available administrative data is technically feasible, current performance is insufficient for clinical decision-making and better suited for health system quality monitoring and comparative effectiveness research applications.


  • Identifying rehabilitation needs as part of secondary prevention in individuals with atrial fibrillation—a Delphi consensus study

    by Caroline M Elnegaard, Signe S Risom, Britt Borregaard, Mickael Bech, Ditte Albrektsen, Jan Astrup, Ann Bovin, Bo Christensen, Jonathan David, Lien Desteghe, et al.

    Aims: This study aimed to establish general consensus on a systematic needs assessment model to determine eligibility for cardiac rehabilitation (CR) as part of secondary prevention in individuals with atrial fibrillation (AF). Specific objectives included identifying relevant needs assessment criteria and establishing consensus on referral criteria. Methods and results: A Delphi study was conducted following the ACCORD guidelines (ACcurate COnsensus Reporting Document) with participation of an international, multi-disciplinary expert panel including physicians, nurses, and other healthcare professionals, across primary and secondary care as well as academic research. The panel also included six people who had AF themselves. The Delphi process involved three iterative rounds of surveys and a video meeting to determine needs assessment criteria and facilitate consensus. Data collection included qualitative feedback and quantitative voting on proposed criteria. Sixty-nine experts participated. There was high agreement on the importance of the study, which identified 12 needs assessment criteria related to AF symptom burden, health-related quality of life, anxiety, medicine adherence, and various risk factors. Whilst there was agreement on the needs assessment model, experts noted that referral criteria should be flexible and tailored to local healthcare settings, emphasizing that each individual's situation is unique. Conclusion: This Delphi study established a needs assessment model that can be adapted to local contexts for individuals with AF. More research is needed to refine referral criteria and ensure effective implementation of individually tailored CR strategies.


    • 1 August 2025
      • Vol. 107  (3) , 980-985

    National Alzheimer's Coordinating Center cerebral neuropathology and cognitive function in atrial fibrillation.

    by Kathryn A Wood, Xinyue Chen, Yi-An Ko, Whitney Wharton, Marla Gearing

    Many studies have shown a relationship between atrial fibrillation (AF) and dementia or Alzheimer's disease (AD). The National Alzheimer's Coordinating Center (NACC) brain autopsy cohort was used to explore neuropathology in AF (N = 3558) using logistic and ordinal logistic regression. AF was significantly associated with differences in CERAD neuritic plaque density (estimated difference 0.76, 95% CI = [0.63, 0.92]). Subjects with AF had higher Braak and NIA/Reagan Scores, indicating worse neuropathology in AF; this was not significant however, after multiple testing adjustment. These findings suggest that the association between AF and higher dementia risk is unlikely mediated by primary dementia-related mechanisms.

  • Open Access

    Concurrent validity testing of the patient perspective of arrhythmia questionnaire

    by Kathryn A. Wood, Yutong Jin, Robert T. Krafty, Jameze H. James, Sivaraman K. Iyer, Nitish Badhwar

    Disease-specific patient reported outcome measures (PROMs) are widely used to evaluate not only a patient’s view of their symptoms, functional status, and health related quality of life, but also clinical benefit of treatments. The Patient Perspective of Arrhythmia Questionnaire (PPAQ) was initially developed as a self-administered, disease-specific PROM for patients with supraventricular tachycardia (SVT) assessing the impact of the arrhythmia and symptoms on patients’ daily activities and physical, emotional, and social functioning. Preliminary evidence of content and construct validity has been previously demonstrated, but only in SVT patients in the U.S. and Poland. The aim of this study was to further evaluate the concurrent validity of the PPAQ in patients having a variety of arrhythmias and to explore whether differences in symptoms existed by gender. In this cross-sectional study, adult cardiac arrhythmia outpatients from a tertiary care, academic medical center completed the 6-item PPAQ, the SF-12, a Fatigue Visual Analog Scale (VAS), the Brief Symptom Inventory (BSI), and the Patient Health Questionnaire (PHQ-9). Included were patients with atrial fibrillation (82.4%), ventricular tachycardia (15.7%), and atrial tachycardia (2%). Descriptive statistics and independent t-tests, pairwise comparisons with Pearson correlations, Goodman Kruskal gamma statistic for ordinal associations, Cronbach’s alpha, and Kuder-Richardson-20 (KR-20) were used to determine concurrent construct validity and internal consistency reliability. Participants (n=51) had a mean age of 59.4 years (± 12.6), were majority male (66.7%) and Caucasian (75%). Preliminary evidence of concurrent construct validity was found based on moderate to strong correlations (range from 0.4 to 0.7) between the PPAQ and other validated measures, as well as strong internal reliability (KR-20 of 0.80 and Cronbach’s alpha of 0.91). The most common symptoms reported were fatigue (60.8%) and heart fluttering (52.9%). Blurred vision (p<0.04), dizziness (p<0.01), and fatigue (p<0.04) were seen significantly more frequently in men compared to women. Results present additional evidence of the validity and reliability of the PPAQ. The PPAQ comprehensively measures the burden of the disease from cardiac arrhythmia patients’ perspective. Validated, reliable, disease-specific PROMs are needed to direct personalized clinical decision-making.


  • Warfarin Versus Non–Vitamin K Inhibitor Medications and Cognitive Disease Progression in Atrial Fibrillation

    by Kathryn A. PhD Wood, Yi-An Ko, Feier Msph Han, Johanna Thunell, Julie Zissimopoulos, Whitney Wharton

    Background: Atrial fibrillation (AF) is associated with cognitive decline. Use of oral anticoagulant (OAC) medications offers a lower risk of dementia, but it is unclear whether differences exist between types of OAC agents. Objective: This was a secondary analysis to explore whether the progression from normal cognition to mild cognitive impairment to dementia differs between adults with AF on warfarin versus non–vitamin K inhibitor medications (NOACs) using data extracted from the National Alzheimer's Coordinating Center clinical case series. Methods: Subjects with AF on OACs, having normal cognition and no stroke at baseline, and at least 1 follow-up visit were included. OAC usage was calculated based on follow-up time and reported previous OAC use. Continuation ratio models (with subject-specific random intercepts) were used to examine the association between OAC type and cognitive diagnosis controlling for cognitive diagnosis from previous visit. Results: Among 1475 eligible participants, 478 reported taking warfarin (n = 396) or NOACs (n = 82) at baseline (mean age of 79 years, 51% females, 84% non-Hispanic White). The median follow-up time was 4 years (interquartile range, 2–7). About 63% continued using either warfarin or NOACs, 44% switched from warfarin to NOACs, and 2% switched from NOACs to warfarin. After adjusting for age, sex, education, race, and cardiovascular clinical comorbidities, no significant association was found between OAC type and cognitive decline (P = .14). Conclusions: We found similar risks of cognitive decline between those on NOACs or warfarin. Future studies should consider effects of age, length of time from AF diagnosis, and OAC adherence on this risk.

  • Open Access

    Machine Learning-Based Identification of High-Risk Patterns in Atrial Fibrillation Ablation Outcomes

    by Mustapha Oloko-Oba, Yijun Liu, Kathryn Wood, Michael S. Lloyd, Joyce C. Ho, Vicki Stover Hertzberg

    Background Atrial fibrillation (AF) is one of the most common types of cardiac arrhythmias, often leading to serious health issues such as stroke, heart failure, and higher mortality rates. Its global impact is rising due to aging populations and growing comorbidities, creating an urgent need for more effective treatment methods. AF ablation, a key treatment option, has success rates that vary widely among patients. Conventional predictors of ablation outcomes, which primarily rely on sociodemographic and clinical factors, fall short of capturing the heterogeneity within patient populations, highlighting the potential for data-driven methods to provide deeper insights into procedural success. Objectives To uncover meaningful patient subgroups based on AF ablation outcomes and identify diagnostic codes associated with failure. Methods Machine learning clustering with must-link and cannot-link constraints was applied to electronic health records to discover meaningful clusters, revealing patient-specific factors influencing procedural success or failure. Statistical analyses, including chi-square tests, were used to identify diagnostic codes significantly associated with ablation failure. Results Out of the 145 diagnostic codes examined, thirteen significant codes were identified and categorized into four primary risk groups, ranked by their impact on procedural outcomes: (1) direct contributors affecting cardiovascular health, (2) indirect factors that contribute to systemic stress, (3) complications related to anticoagulation and hemorrhagic risks that can impact bleeding management, and (4) broader health indicators reflecting a general health burden that reduce patients resilience to procedural stress. Conclusions This study shows the importance of cardiovascular and non-cardiovascular factors in AF ablation outcomes, emphasizing the need for a more comprehensive pre-procedural evaluation. It also contributes to the application of machine learning in personalized risk assessment for AF and advancing individualized care strategies that may improve ablation success.

  • Open Access

    Predicting Atrial Fibrillation Ablation Outcomes: A Machine Learning Approach Leveraging a Large Administrative Claims Database

    by Yijun Liu, Mustapha Oloko-Oba, Kathryn Wood, Michael S. Lloyd, Joyce C. Ho, Vicki Stover Hertzberg

    Background: Atrial fibrillation (AF) ablation is an effective treatment for reducing episodes and improving quality of life in patients with AF. However, in some patients there are only modest long-term AF-free rates after AF ablation. There is a need to address the limited benefits some patients experience by developing predictive algorithms to improve AF ablation outcomes. Objective: The authors aim to utilize machine learning models on claims data to explore if innovative coding models may lead to better patient outcomes than use of traditional stroke risk score prediction. Methods: The Merative MarketScan® Research Medicare data was used to examine claims for AF ablation. To predict 1-year AF-free outcomes after AF ablation, logistic regression and XGBoost models were used. Model predictions were compared with established risk scores CHADS 2 and CHA 2 DS 2 -VASC. These models were also assessed on subgroups of patients with paroxysmal AF, persistent AF, and both AF and atrial flutter from October 2015 onwards. Results: The sample included 14,521 patients with claims for AF ablation. XGBoost achieved an area under the receiver operating characteristic curve (AUC) of 0.525, 0.521, and 0.527 for the entire AF ablation population, female, and male, respectively. Within the subgroups, machine learning models performed the best for the paroxysmal AF subgroup using ICD codes, demographic information, and comorbidity indexes, achieving an AUC of 0.546. Conclusion: Machine learning models outperformed CHADS 2 and CHA 2 DS 2 -VASC in all AF ablation patient groups (whole population, female, and male). Using patient data for those who had their AF ablation on or after October 2015, machine learning models performed best in all subgroups and the population, indicating that including ICD codes in machine learning models may improve performance.

  • Western Diet and Inflammatory Mechanisms in African American Adults With Heart Failure

    by Erica Davis, Sandra B. Dunbar, Melinda K. Higgins, Kathryn Wood, Erin Ferranti, Alanna A. Morris, Brittany Butts

    Background: Black adults have a higher risk for heart failure (HF) than others, which may be related to higher cardiovascular risk factors and also inflammatory dietary patterns. The Western diet is associated with inflammation and contributes to HF. Trimethylamine N-oxide is a diet-linked metabolite that contributes to inflammation and is associated with higher tumor necrosis factor-alpha (TNF-α) levels, especially in HF populations. The dietary inflammatory index score measures a diet’s inflammatory potential and food’s inflammatory effects. Objective: The purpose of this pilot study was to explore associations between the Western diet, dietary inflammatory index, trimethylamine N-oxide, relevant covariates and variables, and TNF-α in Black persons with HF. Methods: Thirty-one Black participants (mean age = 55 years, 68% women) with HF were enrolled. Trimethylamine N-oxide and TNF-α levels were analyzed using immunoassays. A food frequency questionnaire was completed, and dietary inflammatory index scores and food groups were calculated. Analyses included correlations and I-test statistics. Results: Mean dietary inflammatory index score was −0.38, noting an anti-inflammatory diet with slightly higher inflammatory diet scores in men compared to women. The dietary inflammatory index score showed a negative association with dietary choline but not with trimethylamine N-oxide or TNF-α. Trimethylamine N-oxide and age were positively correlated, along with the correlation for TNF-α with a moderate effect size. No relationship was found among dietary inflammatory index, TNF-α, and trimethylamine N-oxide variables. Discussion: A greater understanding of intake of inflammatory foods and relationships with immune factors is warranted to inform intervention development. In Black adults with HF, it is important to consider the intake of inflammatory foods as increased age may affect the retention of dietary metabolites. Metabolites may also increase the levels of inflammation. Knowledge about these relationships could lead to tailored dietary interventions based on diet, age, and culture patterns.